Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Acute Kidney Injury | Research article

Population attributable risk estimates of risk factors for contrast-induced acute kidney injury following coronary angiography: a cohort study

Authors: Li Lei, Yan Xue, Zhaodong Guo, Bowen Liu, Yibo He, Feier Song, Jin Liu, Guoli Sun, Liling Chen, Kaihong Chen, Zhiqi Su, Li Pan, Zhidong Huang, Yulu Huang, Xiuqiong Huang, Shiqun Chen, Jiyan Chen, Yong Liu

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Contrast-induced acute kidney injury (CI-AKI) is a common complication with poor outcomes following coronary angiography (CAG) or percutaneous coronary intervention (PCI). However, no study has explored the population attributable risks (PARs) of the CI-AKI risk factors. Therefore, we aimed to identify the independent risk factors of CI-AKI and estimate their PARs.

Methods

We analyzed 3450 consecutive patients undergoing CAG/PCI from a prospective cohort in Guangdong Provincial People’s Hospital. CI-AKI was defined as a serum creatinine elevation ≥50% or 0.3 mg/dL from baseline within the first 48 to 72 h after the procedure. Independent risk factors for CI-AKI were evaluated through stepwise approach and multivariable logistic regression analysis, and those that are potentially modifiable were of interest. PARs of independent risk factors were calculated with their odds ratios and prevalence among our cohort.

Results

The overall incidence of CI-AKI was 7.19% (n = 248), which was associated with increased long-term mortality. Independent risk factors for CI-AKI included heart failure (HF) symptoms, hypoalbuminemia, high contrast volume, hypotension, hypertension, chronic kidney disease stages, acute myocardial infarction and age > 75 years. Among the four risk factors of interest, the PAR of HF symptoms was the highest (38.06%), followed by hypoalbuminemia (17.69%), high contrast volume (12.91%) and hypotension (4.21%).

Conclusions

These modifiable risk factors (e.g., HF symptoms, hypoalbuminemia) could be important and cost-effective targets for prevention and treatment strategies to reduce the risk of CI-AKI. Intervention studies targeting these risk factors are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allen D, Ma B, Leung K, Graham M, Pannu N, Traboulsi M, Goodhart D, Knudtson M, James M. Risk prediction models for contrast-induced acute kidney injury accompanying cardiac catheterization: systematic review and meta-analysis. Can J Cardiol. 2017;33(6):724–36.CrossRef Allen D, Ma B, Leung K, Graham M, Pannu N, Traboulsi M, Goodhart D, Knudtson M, James M. Risk prediction models for contrast-induced acute kidney injury accompanying cardiac catheterization: systematic review and meta-analysis. Can J Cardiol. 2017;33(6):724–36.CrossRef
2.
go back to reference Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380(22):2146–55.CrossRef Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380(22):2146–55.CrossRef
3.
go back to reference Yang Y, George KC, Luo R, Cheng Y, Shang W, Ge S, Xu G. Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. BMC Nephrol. 2018;19(1):374.CrossRef Yang Y, George KC, Luo R, Cheng Y, Shang W, Ge S, Xu G. Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. BMC Nephrol. 2018;19(1):374.CrossRef
4.
go back to reference Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.CrossRef Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.CrossRef
5.
go back to reference Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control. 2007;18(5):571–9.CrossRef Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control. 2007;18(5):571–9.CrossRef
6.
go back to reference Liu Y, Liang X, Xin S, Liu J, Sun G, Chen S, Cen X, Dai X, He Y, Song F, et al. Risk factors for contrast-induced acute kidney injury (CI-AKI): protocol for systematic review and meta-analysis. BMJ Open. 2019;9(8):e030048.CrossRef Liu Y, Liang X, Xin S, Liu J, Sun G, Chen S, Cen X, Dai X, He Y, Song F, et al. Risk factors for contrast-induced acute kidney injury (CI-AKI): protocol for systematic review and meta-analysis. BMJ Open. 2019;9(8):e030048.CrossRef
7.
go back to reference Liu Y, Chen J, Tan N, Zhou Y, Yu D, Chen Z, He Y, Liu Y, Luo J, Huang W, et al. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv. 2015;8(6):e001859.CrossRef Liu Y, Chen J, Tan N, Zhou Y, Yu D, Chen Z, He Y, Liu Y, Luo J, Huang W, et al. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv. 2015;8(6):e001859.CrossRef
8.
go back to reference Jiang W, Yu J, Xu J, Shen B, Wang Y, Luo Z, Wang C, Ding X, Teng J. Impact of cardiac catheterization timing and contrast media dose on acute kidney injury after cardiac surgery. BMC Cardiovasc Disord. 2018;18(1):191.CrossRef Jiang W, Yu J, Xu J, Shen B, Wang Y, Luo Z, Wang C, Ding X, Teng J. Impact of cardiac catheterization timing and contrast media dose on acute kidney injury after cardiac surgery. BMC Cardiovasc Disord. 2018;18(1):191.CrossRef
9.
go back to reference Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9.CrossRef Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9.CrossRef
10.
go back to reference Chi G, Gibson CM, Liu Y, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ. Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: analysis from the APEX trial. Am J Hematol. 2019;94(1):21–8.CrossRef Chi G, Gibson CM, Liu Y, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ. Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: analysis from the APEX trial. Am J Hematol. 2019;94(1):21–8.CrossRef
11.
go back to reference Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–9.PubMed Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–9.PubMed
12.
go back to reference Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, et al. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the American college of emergency physicians, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am College Cardiol. 2011;57(19):1920–59.CrossRef Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, et al. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the American college of emergency physicians, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am College Cardiol. 2011;57(19):1920–59.CrossRef
13.
go back to reference Willey J, Moon Y, Kahn E, Rodriguez C, Rundek T, Cheung K, Sacco R, Elkind M. Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. J Am Heart Assoc. 2014;3(5):e001106.CrossRef Willey J, Moon Y, Kahn E, Rodriguez C, Rundek T, Cheung K, Sacco R, Elkind M. Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. J Am Heart Assoc. 2014;3(5):e001106.CrossRef
14.
go back to reference Zhang J, Fu X, Jia X, Fan X, Gu X, Li S, Wu W, Fan W, Su J, Hao G, et al. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention. Acta Radiol. 2010;51(6):641–8.CrossRef Zhang J, Fu X, Jia X, Fan X, Gu X, Li S, Wu W, Fan W, Su J, Hao G, et al. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention. Acta Radiol. 2010;51(6):641–8.CrossRef
15.
go back to reference Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail. 2011;17(6):451–8.CrossRef Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail. 2011;17(6):451–8.CrossRef
16.
go back to reference Ancion A, Allepaerts S, Robinet S, Oury C, Pierard L, Lancellotti P. Serum albumin level and long-term outcome in acute heart failure. Acta Cardiol. 2019;74(6):465–71.CrossRef Ancion A, Allepaerts S, Robinet S, Oury C, Pierard L, Lancellotti P. Serum albumin level and long-term outcome in acute heart failure. Acta Cardiol. 2019;74(6):465–71.CrossRef
17.
go back to reference India State-Level Disease Burden Initiative Malnutrition Collaborators. The burden of child and maternal malnutrition and trends in its indicators in the states of India: the global burden of disease study 1990-2017. Lancet Child Adolescent Health. 2019;3(12):855–70.CrossRef India State-Level Disease Burden Initiative Malnutrition Collaborators. The burden of child and maternal malnutrition and trends in its indicators in the states of India: the global burden of disease study 1990-2017. Lancet Child Adolescent Health. 2019;3(12):855–70.CrossRef
18.
go back to reference Ota A, Kondo N, Murayama N, Tanabe N, Shobugawa Y, Kondo K. Serum albumin levels and economic status in Japanese older adults. PLoS One. 2016;11(6):e0155022.CrossRef Ota A, Kondo N, Murayama N, Tanabe N, Shobugawa Y, Kondo K. Serum albumin levels and economic status in Japanese older adults. PLoS One. 2016;11(6):e0155022.CrossRef
19.
go back to reference Murat SN, Kurtul A, Yarlioglues M. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology. 2015;66(8):732–7.CrossRef Murat SN, Kurtul A, Yarlioglues M. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology. 2015;66(8):732–7.CrossRef
20.
go back to reference Hassan K, Fadi H. Is hypoalbuminemia a prognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients? Ther Clin Risk Manag. 2014;10:787–95.CrossRef Hassan K, Fadi H. Is hypoalbuminemia a prognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients? Ther Clin Risk Manag. 2014;10:787–95.CrossRef
21.
go back to reference Zhang E, Lu Y, Chen G, Huang L, Zhang J, Wang C, Qin Q. Predictive value of Hepatorenal status in contrast-induced nephropathy among patients receiving coronary angiography and/or intervention: a systematic review and meta-analysis. Angiology. 2019;70(7):633–41.CrossRef Zhang E, Lu Y, Chen G, Huang L, Zhang J, Wang C, Qin Q. Predictive value of Hepatorenal status in contrast-induced nephropathy among patients receiving coronary angiography and/or intervention: a systematic review and meta-analysis. Angiology. 2019;70(7):633–41.CrossRef
22.
go back to reference Zhang W, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55(4):820–9.CrossRef Zhang W, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55(4):820–9.CrossRef
23.
go back to reference Bilasy M, Oraby M, Ismail H, Maklady F. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures. J Interv Cardiol. 2012;25(4):404–10.CrossRef Bilasy M, Oraby M, Ismail H, Maklady F. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures. J Interv Cardiol. 2012;25(4):404–10.CrossRef
24.
go back to reference Borekci A, Gur M, Turkoglu C, Cayli M, Selek S, Kaypakli O, Ucar H, Coskun M, Seker T, Koc M, et al. Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2015;66(4):339–45.CrossRef Borekci A, Gur M, Turkoglu C, Cayli M, Selek S, Kaypakli O, Ucar H, Coskun M, Seker T, Koc M, et al. Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2015;66(4):339–45.CrossRef
25.
go back to reference Lee E, Kim W, Kim J, Chin J, Choi D, Sim J, Choo S, Chung C, Lee J, Choi I. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g/dl. Anesthesiology. 2016;124(5):1001–11.CrossRef Lee E, Kim W, Kim J, Chin J, Choi D, Sim J, Choo S, Chung C, Lee J, Choi I. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g/dl. Anesthesiology. 2016;124(5):1001–11.CrossRef
26.
go back to reference McDonald J, McDonald R, Comin J, Williamson E, Katzberg R, Murad M, Kallmes D. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology. 2013;267(1):119–28.CrossRef McDonald J, McDonald R, Comin J, Williamson E, Katzberg R, Murad M, Kallmes D. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology. 2013;267(1):119–28.CrossRef
27.
go back to reference Ehrmann S, Quartin A, Hobbs B, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017;43(6):785–94.CrossRef Ehrmann S, Quartin A, Hobbs B, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017;43(6):785–94.CrossRef
Metadata
Title
Population attributable risk estimates of risk factors for contrast-induced acute kidney injury following coronary angiography: a cohort study
Authors
Li Lei
Yan Xue
Zhaodong Guo
Bowen Liu
Yibo He
Feier Song
Jin Liu
Guoli Sun
Liling Chen
Kaihong Chen
Zhiqi Su
Li Pan
Zhidong Huang
Yulu Huang
Xiuqiong Huang
Shiqun Chen
Jiyan Chen
Yong Liu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01570-6

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue